---
title: "CE Mark Won't Pay Your Bills. Reimbursement Will."
description: "Why a CE mark alone does not pay the bills: a practical look at European reimbursement pathways, payer evidence expectations and when to build market access into your device development plan."
url: https://qbdgroup.com/en/webinars/ce-mark-wont-pay-your-bills-reimbursement-will
type: "Webinar"
language: en
published: 2026-09-30
author: "Anne-Sophie Grell & Marco Kalms"
category: "Regulatory Affairs"
publisher: "QbD Group"
citation: "QbD Group, \"CE Mark Won't Pay Your Bills. Reimbursement Will.\", https://qbdgroup.com/en/webinars/ce-mark-wont-pay-your-bills-reimbursement-will"
---
# CE Mark Won't Pay Your Bills. Reimbursement Will.
> Why a CE mark alone does not pay the bills: a practical look at European reimbursement pathways, payer evidence expectations and when to build market access into your device development plan.

_Why CE marking alone is not a market access strategy, and how to build reimbursement into your device plan from day one_

🕐 3 PM CET

## About This Webinar

For many medical device companies, the CE mark feels like the finish line. In reality, it is only the starting point. Without a reimbursement strategy, even a fully compliant device can fail to reach patients, because hospitals and healthcare systems will not pay for it.

In this 60-minute webinar, QbD Group looks beyond regulatory approval and into the economic reality of market access. Anne-Sophie Grell and Marco Kalms explain how reimbursement pathways differ across European markets, what evidence payers and health technology assessment bodies expect, and when reimbursement planning should start in your development timeline.

The session connects regulatory strategy with market access thinking, showing how early decisions on clinical evidence, intended use and target markets directly influence your reimbursement options later.

## What You'll Learn

- Why CE marking alone does not guarantee market uptake or revenue
- How reimbursement systems differ across key European markets
- What evidence payers and HTA bodies expect beyond the technical documentation
- When to start reimbursement and market access planning in your device development
- How regulatory and reimbursement strategies can reinforce each other instead of competing for budget

## Speakers

### Anne-Sophie Grell

**Regulatory Affairs Expert · QbD Group**

Anne-Sophie Grell supports medical device manufacturers with regulatory strategy and MDR compliance, helping teams align their technical documentation and evidence plans with both regulatory and market access requirements.

### Marco Kalms

**Regulatory Affairs & Market Access Expert · QbD Group**

Marco Kalms advises medical device companies on regulatory affairs and market access, with a focus on turning CE marking into a viable commercial pathway through early reimbursement planning.

## Who Should Attend

- Regulatory Affairs and Market Access managers at medical device companies
- MedTech founders and scale-ups preparing their first CE-marked product
- Commercial and business development leaders planning European market entry
- Clinical evidence teams aligning study plans with payer expectations
---
Source: https://qbdgroup.com/en/webinars/ce-mark-wont-pay-your-bills-reimbursement-will — © QbD Group. Quote freely with attribution and a link back.